COMMUNIQUÉS West-GlobeNewswire

Parexel Showcases Industry-Leading Hematology Expertise with Presentation of 10 Research Posters at the American Society of Hematology (ASH) Annual Meeting
04/12/2025
Scientific and medical presence at ASH underscores Parexel’s proven expertise at premier event for classical and malignant hematology RALEIGH, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Parexel , a leading global clinical [...]
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
04/12/2025
BGE-102 was well-tolerated in SAD and initial MAD cohorts, with a pharmacokinetic profile supporting once-daily oral dosing Strong target engagement: BGE-102 achieved 90-98% suppression of IL-1β, a cytokine directly [...]
Akari Therapeutics Provides Corporate Update and Highlights its ADC Payload Innovation Expected to Drive Value in New CEO Corner Segment
04/12/2025
Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for antibody drug conjugates [...]
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
04/12/2025
Pancreatic cancer multi-center clinical trial in U.S. is underway; patient recruitment expected to be completed by the end of Q1 2026 JERUSALEM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or [...]
Marius Pharmaceuticals CEO Shalin Shah Invited to Speak at Landmark FDA Expert Panel on Testosterone Replacement Therapy for Men
04/12/2025
RALEIGH, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced that its Chief Executive Officer, Shalin Shah, will speak at the FDA Expert Panel on Testosterone Replacement Therapy for Men [...]
New Study Shows Promising Advancement in Stroke Treatment That Aligns With the Philosophy Behind Anathapindika’s Detoxing Supplements
04/12/2025
Anathapindika’s Supplements Are Unique in Their Focus on Detoxification. Recent Research Surrounding Stroke Recovery Could Support Their Use as Natural Brain and Body Cleansing Agents. Fort Lauderdale, FL, Dec. 04, 2025 [...]
Anathapindika Health Enters Harvest Natural Foods
04/12/2025
The Detoxification Dietary Supplement Brand Is Officially in Another West Coast Brick-and-Mortar Location Fort Lauderdale, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Anathapindika Health sells a trio of groundbreaking [...]
Last Patient Completes Biofrontera’s Phase 1 Pharmacokinetics Study of Ameluz® for Treatment of Actinic Keratoses on the Trunk and Extremities
04/12/2025
Phase 1 Maximal-use Phase 1 study evaluated pharmacokinetic (PK) profile following application of 3 tubes of Ameluz ® over treatment area of 240 cm 2 Completion of this study marks a key milestone towards a planned [...]
BeautyHealth Releases Third Annual Skintuition Report
04/12/2025
Latest volume reveals how shifting consumer preferences are redefining modern aesthetics LONG BEACH, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial [...]
USOSM Secures Partnership with Northern Virginia Oral, Maxillofacial & Implant Surgery
04/12/2025
IRVING, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial surgeons – has formalized a new [...]
McLaren Bay Region Raises the Bar on Emergency Department Communication with MEDI+SIGN
04/12/2025
BAY CITY, Mich., Dec. 04, 2025 (GLOBE NEWSWIRE) -- McLaren Bay Region has equipped its Emergency Department treatment rooms with MEDI+SIGN Digital Whiteboards and Door Displays to enhance the patient experience and [...]
Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
04/12/2025
AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today announced new biomarker data identifying a molecular signature that predicts [...]
DOGP Moves to Nearly Double DOG Token Holdings Through Strategic Agreement
04/12/2025
“Expanding Participation in a Digital Ecosystem With Real-World Utility” Mesquite, NV, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV December 4, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP) today announced that its [...]
Communiqué de presse : Sanofi finalise l’acquisition de Vicebio
04/12/2025
Sanofi finalise l’acquisition de Vicebio Paris, le 4 décembre 2025 . Sanofi annonce aujourd’hui la finalisation de l’acquistion de Vicebio Ltd (« Vicebio ») . Cette acquisition apporte à Sanofi un candidat-vaccin [...]
Press Release: Sanofi completes acquisition of Vicebio
04/12/2025
Sanofi completes acquisition of Vicebio Paris, December 4, 2025 . Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”) . This acquisition brings an early-stage combination vaccine candidate for [...]
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
04/12/2025
Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China Collaboration designed to accelerate and expand the [...]
Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway
04/12/2025
RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative biologic drug therapies for chronic wounds, announced [...]
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
04/12/2025
Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple antibody-drug conjugates (ADCs), generating clinical data in global [...]
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
04/12/2025
Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026 Topline results from Phase 2 VISTA trial of ML-007C-MA for Alzheimer’s disease psychosis expected in the [...]

Pages